This will be the first microdosing trial in history.
Psychedelics could be our secret weapon against addiction and depression, among many others.
This knowledge could be used to improve social interactions in patients with mental disorders.
Just imagine a music therapy session spiced up with some psychedelics.
However, it’s not exactly better, and it’s probably not the kind of expanded consciousness you’d want.
A new study sheds some light on what drug-takers have known or years: acid trips last a long time.
Altered States is a great scholarly work that attempts to dissect American Buddhism and psychedelics.
Few drugs have had a more undeserving bad rep as LSD, but acid is finally making a comeback, it seems.
British researchers investigated the long term effects of LSD. It’s well documented that LSD may induce a psychosis, and participants involved with the study did indeed score higher on a test meant to gauge the disorder. Weeks after the first hit, however, the participants exhibited increased optimism and trait openness worked mid to long term.
The right music can evoke powerful emotions seemingly out of the blue, but under the influence of LSD the musical experience is enhanced even further. This according to the Beckley/Imperial Psychedelic Research Programme which tested this long held assumption under a modern placebo-controlled study for the very first time.
Two new studies, independently published in the same journal, found that consciousness expanding substances like LSD or psilocybin (the psychoactive substance found in ‘magic mushrooms’) couldn’t be linked with mental health problems in the general population. Moreover, according to data fed from a nationwide survey, psychedelics make people less prone to suicide and suicidal thinking than the general population. Previously, studies showed that psychedelics have significant results in treating addiction and post traumatic stress, under guidance and supervision. The researchers stress, however, that some individuals may experience adverse psychological effects.
After four decades without any published scientific information on LSD, a new study has reopened the door for the psychedelic drug. Psychiatrists in Santa Cruz, California published results from the first controlled medical trial of LSD in over 40 years, highlighting potential medical benefits.
A new Swiss study implying LSD assisted treatment has recently been conducted. Its very positive results seem to second the findings that were once commonly accepted (especially during the 1960’s). LSD (i.e. lysergic acid diethylamide) is a compound whose properties are psychoactive and were first discovered by dr. Albert Hofmann in 1943. The doctor was the first to conduct series
Researchers at the Norwegian University of Science and Technology’s (NTNU) Department of Neuroscience analyzed a massive survey of 130,000 randomly chosen people from the US to see whether there is any association between psychedelic drug use and mental health problems – a claim that has had large circulation and is often cited, despite little research in this respect. Their findings suggest